Walleye Capital’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $150K | Sell |
62,313
-168,687
| -73% | -$407K | ﹤0.01% | 1458 |
|
|
2025
Q1 | $511K | Buy |
+231,000
| New | +$511K | ﹤0.01% | 1077 |
|
|
2023
Q4 | – | Sell |
-19,170
| Closed | -$192K | – | 2696 |
|
|
2023
Q3 | $192K | Buy |
19,170
+47
| +0.2% | +$470 | ﹤0.01% | 1505 |
|
|
2023
Q2 | $238K | Buy |
+19,123
| New | +$238K | ﹤0.01% | 1270 |
|
|
2022
Q2 | – | Sell |
-24,320
| Closed | -$858K | – | 2522 |
|
|
2022
Q1 | $858K | Buy |
+24,320
| New | +$858K | 0.02% | 685 |
|
|
2021
Q4 | – | Sell |
-8,163
| Closed | -$401 | – | 2176 |
|
|
2021
Q3 | $401 | Sell |
8,163
-22,483
| -73% | -$1.1K | 0.01% | 865 |
|
|
2021
Q2 | $1.28K | Buy |
+30,646
| New | +$1.28K | 0.04% | 337 |
|
|
2021
Q1 | – | Sell |
-170,399
| Closed | -$4.78K | – | 1267 |
|
|
2020
Q4 | $4.78K | Buy |
+170,399
| New | +$4.78K | 0.32% | 34 |
|